Kimberly S Hannan

Kimberly S. Hannan serves as a Purchasing Agent responsible for managing the acquisition of specialized scientific and medical equipment critical to public health and laboratory operations. In this role, she ensures compliance with federal procurement regulations while aligning purchases with agency mission needs, typically overseeing solicitations for analytical instruments, diagnostic substances, and precision medical devices. Her work supports the procurement lifecycle from requirement validation through contract award and administration, emphasizing technical accuracy, regulatory adherence, and timely delivery of mission-critical supplies. While specific contractor relationships are not publicly enumerated, Hannan routinely engages with manufacturers and distributors specializing in laboratory and medical device technologies, fostering partnerships with both large-scale suppliers and small businesses capable of meeting stringent technical specifications. Her procurement approach prioritizes vendor reliability, product certification, and adherence to quality standards such as ISO 13485 and FDA regulatory requirements, ensuring that acquired equipment meets the operational demands of high-precision environments. Hannan demonstrates a strong commitment to small business participation, with over 20% of her acquisitions structured as Total Small Business Set-Asides under FAR 19.5. Her contracting patterns reflect a deliberate focus on leveraging small business capabilities in technical manufacturing sectors, though the majority of her portfolio remains open to full and open competition, indicating a balanced approach that prioritizes both competition and socioeconomic goals. Her primary procurement focus lies in NAICS 334516 (Analytical Laboratory Instrument Manufacturing) and 325413 (In-Vitro Diagnostic Substance Manufacturing), reflecting deep expertise in life sciences and diagnostic technologies. She frequently acquires precision instruments for clinical testing, laboratory automation systems, and specialized medical devices, demonstrating technical fluency in biopharmaceutical and laboratory diagnostics domains. Her work ensures the agency maintains access to cutting-edge, compliant, and reliable diagnostic and analytical capabilities.